IRADIMED CORPORATION
US ˙ NasdaqGM ˙ US46266A1097

SecurityIRMD / IRADIMED CORPORATION
InstitutionLazard Asset Management Llc
Latest Disclosed Ownership48,914 shares
Latest Disclosed Value $ 4,708,462
Lazard Asset Management Llc reports 15.39% increase in ownership of IRMD / IRADIMED CORPORATION

On May 15, 2026 - Lazard Asset Management Llc filed a 13F-HR form disclosing ownership of 48,914 shares of IRADIMED CORPORATION (US:IRMD) valued at $4,708,462 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 42,390 shares of IRADIMED CORPORATION. This represents a change in shares of 15.39% during the quarter. The current value of the position is $4,552,426 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F IRADIMED COM 46266A109 48,914 6,524 15.39 4,708 14.19 0.0077
2026-02-17 2025-12-31 13F IRADIMED COM 46266A109 42,390 2,216 5.52 4,124 44.26 0.0070
2025-11-14 2025-09-30 13F IRADIMED COM 46266A109 40,174 -936 -2.28 2,859 142,800.00 0.0038
2025-08-14 2025-06-30 13F IRADIMED Common Stock 46266A109 41,110 2,036 5.21 2 0.00 0.0034
2025-05-15 2025-03-31 13F IRADIMED Common Stock 46266A109 39,074 5,782 17.37 2 100.00 0.0031
2025-02-14 2024-12-31 13F IRADIMED Common Stock 46266A109 33,292 8,773 35.78 2 0.00 0.0027
2024-11-14 2024-09-30 13F IRADIMED Common Stock 46266A109 24,519 9,005 58.04 1 0.0016
2024-08-14 2024-06-30 13F IRADIMED Common Stock 46266A109 15,514 9,406 153.99 1 0.0009
2024-07-09 2024-03-31 13F/A-1 IRADIMED Common Stock 46266A109 6,108 -210 -3.32 0 0.0003
2024-05-14 2024-03-31 13F IRADIMED Common Stock 46266A109 6,108 -210 0 0.0003
2024-02-14 2023-12-31 13F IRADIMED Common Stock 46266A109 6,318 293 4.86 0 0.0004
2023-11-14 2023-09-30 13F IRADIMED Common Stock 46266A109 6,025 827 15.91 0 0.0004
2023-08-15 2023-06-30 13F IRADIMED Common Stock 46266A109 5,198 143 2.83 0 0.0003
2023-05-15 2023-03-31 13F IRADIMED Common Stock 46266A109 5,055 -637 -11.19 0 -100.00 0.0003
2023-02-15 2022-12-31 13F IRADIMED Common Stock 46266A109 5,692 12 0.21 161 -5.29 0.0002
2022-11-14 2022-09-30 13F IRADIMED Common Stock 46266A109 5,680 -44 -0.77 170 -12.37 0.0002
2022-08-09 2022-06-30 13F IRADIMED Common Stock 46266A109 5,724 3,593 168.61 194 104.21 0.0003
2022-05-13 2022-03-31 13F IRADIMED Common Stock 46266A109 2,131 68 3.30 95 0.00 0.0001
2022-02-09 2021-12-31 13F IRADIMED Common Stock 46266A109 2,063 2,063 95 0.0001
2021-11-15 2021-09-30 13F IRADIMED Common Stock 46266A109 0 -824 -100.00 0 -100.00
2021-08-12 2021-06-30 13F IRADIMED Common Stock 46266A109 824 824 24 0.0000
2021-05-14 2021-03-31 13F IRADIMED Common Stock 46266A109 0 -649 -100.00 0 -100.00
2021-02-11 2020-12-31 13F IRADIMED Common Stock 46266A109 649 -151 -18.88 14 -17.65 0.0000
2020-11-13 2020-09-30 13F IRADIMED Common Stock 46266A109 800 -1,015 -55.92 17 -59.52 0.0000
2020-08-13 2020-06-30 13F IRADIMED Common Stock 46266A109 1,815 -278 -13.28 42 -4.55 0.0001
2020-05-14 2020-03-31 13F IRADIMED Common Stock 46266A109 2,093 1,357 184.38 44 158.82 0.0001
2020-02-13 2019-12-31 13F IRADIMED Common Stock 46266A109 736 296 67.27 17 88.89 0.0000
2019-11-14 2019-09-30 13F IRADIMED Common Stock 46266A109 440 440 9 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.